期刊文献+

放射治疗在眼眶横纹肌肉瘤中的应用

Radiotherapy for orbital rhabdomyosarcoma
下载PDF
导出
摘要 目的同顾性分析放射治疗眼眶横纹肌肉瘤的效果。方法对19例眼眶横纹肌肉瘤患者给予放射治疗,男10例,女9例。全组中位照射剂量45(32.4~54)Gy,中位随访57.7(29~98)个月。结果 3年生存率89%,5年生存率83%;3年无病生存率84%,5年无病生存率78%。其中3例治疗后局部复发,1例远处转移。结论选择合理照射技术,给予个体化剂量照射,对眼眶横纹肌肉瘤患者可以获得长期生存。 Objective To analyze retrospectively the outcome of treating orbital rhabdomyosarcoma with radiotherapy. Meth- ods From December 2002 to May 2008, 19 patients ( ten males and nine females) aged 5 to 18 with orbital rhabdomyosarcoma re- ceived radiotherapy. The media dose was 45 Gy ( range, 32.4 - 54 Gy). The media duration of follow - up was 57.7 months ( range, 29 - 98 months). Results The overall survival rate at 3 and 5 years was 89% and 83 % . The disease - free survival at 3 and 5 years was 84% and 78% respectively. Treatment failure was shown by local relapse in three patients and distant metastasis in one patient. Conclusions Orbital rhabdomyosarcoma can be cured with radiotherapy.
出处 《武警医学》 CAS 2011年第8期669-672,共4页 Medical Journal of the Chinese People's Armed Police Force
关键词 横纹肌肉瘤 眼眶 放射治疗 rhabdomyosarcoma orbit radiotherapy
  • 相关文献

参考文献22

  • 1K Engberg. Thyristor Switched Capacitors, TSC, in Theory and Practice[A]. Fourth International Conference on AC and DCTransmission[C], London, 1985.
  • 2徐爱钧.功率因数自动补偿装置[J].电气自动化,1992(5):28-31. 被引量:6
  • 3Sagerman R H, Tretter P, Ellsworth R M. The treatment of orbit rhadomyosarcoma of children with primary radia- tion therapy [ J ]. Am J Roentgenol Radium Ther Nucl Med, 1972,114(1) :31 -34.
  • 4Maurer H M, Beltangady M, Gehan E A, et al. The In- tergroup Rhabdomyosarcoma Study - I: a final report [J]. Cancer, 1988, 61(2) :209 -220.
  • 5Koscielnak E, Jurgens H, Winkler K, et al. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German cooperative soft tissue sarcoma study [ J ]. Cancer, 1992, 70 (10) : 2557 - 2567.
  • 6Rousseau P, Flamant F, Quintana E, et al. Primary chem- otherapy in rhabdomyosarcoma and other malignant mesen- chymal tumours of the orbit: Results of the International Society of Paediatric Oncology MMT 84 Study [ J ]. J Clin Oncol, 1994,12(3) :516 -521.
  • 7Oberlin O, Rey A, Anderson J, et al. Treatment of or- bital rhabdomyosarcoma: Survival and late effects of treatment--Resuks of an international workshop [ J ]. J Clin Oncol, 2001,19 ( 1 ) : 197 - 204.
  • 8Heyn R, Ragab A, Raney R B, et al. Late effects of therapy in orbital rhabdomyosarcoma in children: A re- port from the Intergroup Rbabdomyosarcoma Study [ J ]. Cancer, 1986,57 (9) : 1738 - 1743.
  • 9Hein P A, Gladstone D J, Bellerive M R, et al. Impor- tance of protocol target definition on the ability to spare normal tissue: An IMRT and 3D - CRT planning com- parison for intraorbital tumors [ J ]. Int J Radiat Oncol Bi- ol Phys,2005,62(5) : 1540 - 1548.
  • 10Raney R B, Maurer H M, Anderson J R, et al. The In- tergroup Rhabdomyosarcoma Study Group (IRSG) : ma- jor lessons from the IRS - I through IRS - IV studies as background for the current IRS - V treatment protocols [J]. Sarcoma, 2001,5(1) :9 - 15.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部